AMED SCARDA「ワクチン開発のための世界トップレベル研究開発拠点の形成事業」合同シンポジウム

*植木 紘史^1,2,3
*Hiroshi Ueki^1,2,3, Sae Aratani⁴, Yoshimi Imawari⁴, Makoto Nakanishi⁴, Yoshihiro Kawaoka^1,2,3,5 (1. The University of Tokyo, Pandemic Preparedness, Infection and Advanced Research Center (Japan), 2. International Virus Infectious Disease Research Center, National Institute of Global Health and Medicine, Japan Institute for Health Security (JIHS) (Japan), 3. Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo (Japan), 4. Division of Cancer Cell Biology, Institute of Medical Science, University of Tokyo (Japan), 5. Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison (USA))

*Yosuke Kurashima^1,2,3,4, Zhongwei Zhang^1,3, Sayuri Murasaki^1,3, Gaku Ohira⁵, Yasunori Matsumoto⁵, Yu Takahashi⁶, Izumi Tanaka^1,3, Hitoshi Ogata^1,3,7, Peter B Ernst^4,9,10, Hisahiro Matsubara⁵, Satoshi Uematsu^11,12, Hiroshi Kiyono^3,4,8,9 (1. Department of Innovative Medicine, Graduate School of Medicine, Chiba University, Chiba (Japan), 2. Institute for Advanced Academic Research/ Research Institute of Disaster Medicine, Chiba University, Chiba (Japan), 3. Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba (Japan), 4. Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), Department of Medicine, School of Medicine, San Diego, CA (USA), 5. Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba (Japan), 6. Food Biochemistry Laboratory, Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo (Japan), 7. Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba (Japan), 8. Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba (Japan), 9. Division of Comparative Pathology and Medicine, Department of Pathology, University of California, San Diego, CA (USA), 10. Center for Veterinary Sciences and Comparative Medicine, University of California, San Diego, CA (USA), 11. Department of Immunology and Genomics, Graduate School of Medicine, Osaka Metropolitan University, Osaka (Japan), 12. Division of Metagenome Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo (Japan))

*Kazuhiro Matsuo¹, Satoru Mizuno¹, Hiroto Takeuchi², Kensuke Takada¹ (1. Institute for Vaccine Research and Development, Hokkaido University (Japan), 2. International Institute for Zoonosis Control, Hokkaido University (Japan))

*Eiryo Kawakami^1,2 (1. Department of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University (Japan), 2. cSIMVa, Chiba University (Japan))

*Shusaku Mizukami^1,2, Sebastian Kjell-Ove Kapell^1,3,4, Shara Bakytbek^1,5, Farzaneh Valanezhad^1,5, Ayako Hyuga^1,5, Shin-Ichi Inoue^1,6, Mya Myat Ngwe Tun^1,7, Haruka Abe^1,8, Yarob Ibraheem^1,5, Vegard Børve Sørdal⁹, Marius Gheorghe⁹, Ioannis Vardaxis⁹, Daiki Mori⁴, Daiki Miura⁴, Yuki Tanaka⁴, Yoko Kuroki^1,10, Shuji Iwashita^1,10, Sayuri Nakamae^1,10, Corazon Cerilla Buerano^1,7, Basu Dev Pandey¹, Taiki Aoshi^1,6, Satoshi Kaneko^1,11, Yuki Takamatsu^1,12, Futoshi Hasebe^1,8, Hitoshi Sasaki^1,10, Kazuhide Onoguchi⁴, Katsuyuki Yui¹³, Trevor Clancy⁹, Kaidre Bendjama⁹, Shinjiro Hamano^1,5, Kouichi Morita¹ (1. Vaccine Research and Development Center (VRDC), DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University (Japan), 2. Deptartment of Immune Regulation, SHIONOGI Global Infectious Diseases Division (SHINE), Institute of Tropical Medicine (NEKKEN), Nagasaki University (Japan), 3. Department of Vaccine Informatics, NEKKEN, Nagasaki University (Japan), 4. NEC Corporation (Japan), 5. Department of Parasitology, NEKKEN, Nagasaki University (Japan), 6. Department of Immunology, Graduate School of Biomedical Sciences, Nagasaki University (Japan), 7. Department of Tropical Viral Vaccine Development, NEKKEN, Nagasaki University (Japan), 8. Vietnam Research Station, NEKKEN, Nagasaki University (Japan), 9. NEC Oncoimmunity AS (Norway), 10. Department of Clinical Product Development, NEKKEN, Nagasaki University (Japan), 11. Deptartment of Eco-epidemiology, NEKKEN, Nagasaki University (Japan), 12. Department of Virology, NEKKEN, Nagasaki University (Japan), 13. SHINE, NEKKEN, Nagasaki University (Japan))

*Reiko Shinkura¹, Peng Gao¹ (1. IQB, The University of Tokyo (Japan))